<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-80371" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Peripheral Vascular Disease</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Gul</surname>
            <given-names>Fahad</given-names>
          </name>
          <aff>Einstein Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Janzer</surname>
            <given-names>Sean F.</given-names>
          </name>
          <aff>Albert Einstein Medical Center, Philadelphia</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Fahad Gul declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sean Janzer declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>6</day>
          <month>6</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-80371.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Peripheral vascular diseases are a significant cause of morbidity and limb loss in the United States. Early identification and risk factor modification are essential to improve the outcomes in patients with peripheral vascular disease. This activity outlines the principles of evaluation and management of peripheral vascular disease and explores the surgical and non-surgical treatment alternatives, and highlights the importance of the interprofessional team in the evaluation of this pathology. Peripheral vascular disease has been associated with multiple risk factors, including smoking, diabetes, prior coronary artery disease, and a sedentary lifestyle. This activity highlights the risk factors for peripheral vascular disease and the role of risk factor modification in the treatment of peripheral vascular disease. The cornerstone for the diagnosis of peripheral vascular disease is a thorough history and physical exam, including the ankle-brachial index. This activity describes the role of the interprofessional team in the evaluation and diagnostic workup of a patient with suspected peripheral vascular disease. It provides a guideline for the interpretation of ankle-brachial-index readings. The treatment of peripheral vascular disease includes risk factor modification, antiplatelet therapy, and exercise as the cornerstone of care in these patients. Appropriate patients with severe disease or lifestyle limiting symptoms are frequently managed with endovascular, surgical, or combined interventional approaches. This activity highlights the importance of the interprofessional team in the management of patients suffering from peripheral arterial disease and the selection of the appropriate intervention.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology for the development of peripheral vascular disease.</p></list-item><list-item><p>Summarize the appropriate evaluation for the diagnosis of peripheral vascular disease.</p></list-item><list-item><p>Describe the management options available for peripheral vascular disease.</p></list-item><list-item><p>Outline interprofessional team strategies for improving care coordination and improve outcomes in patients with peripheral vascular disease.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=80371&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=80371">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-80371.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Peripheral vascular disease (PVD) includes peripheral arterial disease (PAD) and venous disease. PAD is a chronic progressive atherosclerotic disease leading to partial or total peripheral vascular occlusion. PAD typically affects the abdominal aorta, iliac arteries, lower limbs,&#x000a0;and&#x000a0;occasionally the&#x000a0;upper extremities.<xref ref-type="bibr" rid="article-80371.r1">[1]</xref>&#x000a0;PAD affects nearly 200 million people worldwide with increasing global importance due to longer life expectancy and prolonged risk factor exposure.<xref ref-type="bibr" rid="article-80371.r2">[2]</xref><xref ref-type="bibr" rid="article-80371.r3">[3]</xref>&#x000a0;Patients with PAD have a variable disease presentation and course with some patients remaining asymptomatic and with others progressing to arterial ulceration, claudication, resting limb ischemia, and limb loss.<xref ref-type="bibr" rid="article-80371.r4">[4]</xref>&#x000a0;PAD is a cardiovascular disease equivalent, with associated high risk fatal and non-fatal cardiovascular events frequently occurring, such as myocardial infarction and stroke.<xref ref-type="bibr" rid="article-80371.r5">[5]</xref>&#x000a0;PAD is a progressive, debilitating systemic disease that requires interprofessional involvement for improved patient outcomes.</p>
      </sec>
      <sec id="article-80371.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Peripheral vascular disease is primarily driven by progressive atherosclerotic disease resulting in the reduction of major organ blood flow and end-organ ischemia. The process of atherosclerosis is complex, with the involvement of numerous cells, proteins, and pathways.&#x000a0;Important non-modifiable and modifiable risk factors have been identified in the advancement of atherosclerosis.</p>
        <p>Risk factors include:<xref ref-type="bibr" rid="article-80371.r4">[4]</xref><xref ref-type="bibr" rid="article-80371.r6">[6]</xref><xref ref-type="bibr" rid="article-80371.r7">[7]</xref><xref ref-type="bibr" rid="article-80371.r8">[8]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Tobacco use</p>
          </list-item>
          <list-item>
            <p>Diabetes mellitus</p>
          </list-item>
          <list-item>
            <p>Hypertension</p>
          </list-item>
          <list-item>
            <p>HIV</p>
          </list-item>
          <list-item>
            <p>High cholesterol</p>
          </list-item>
          <list-item>
            <p>Age more than 50 years</p>
          </list-item>
          <list-item>
            <p>Elevated homocysteine levels</p>
          </list-item>
          <list-item>
            <p>BMI greater than 30</p>
          </list-item>
          <list-item>
            <p>Family history of cardiovascular disease</p>
          </list-item>
        </list>
        <p>Of the above risk factors, smoking is associated with the highest risk of PAD development with an odds ratio of 2.7 (95% CI 2.4&#x02013;3.1). History of cardiovascular disease and diabetes are also significant risk factors with odds ratios of 2.6 (95% CI 2.2-3) and 1.9 (1.7-2.1), respectively.<xref ref-type="bibr" rid="article-80371.r9">[9]</xref></p>
      </sec>
      <sec id="article-80371.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Peripheral vascular disease affects nearly 200 million people&#x000a0;worldwide, including approximately 40 to 45 million Americans.<xref ref-type="bibr" rid="article-80371.r10">[10]</xref>&#x000a0;The disease is uncommon in younger populations; however, incidence increases sharply, with over 20% of people over 80 years old having PAD.<xref ref-type="bibr" rid="article-80371.r11">[11]</xref>&#x000a0;Data on gender differences is conflicting. In the Framingham study, intermittent claudication (IC) was more prevalent in men compared to women&#x000a0;(1.9% to 0.8%;&#x000a0;ratio 2.38).<xref ref-type="bibr" rid="article-80371.r12">[12]</xref>&#x000a0;This finding was consistent with the Rotterdam study that found men were 1.83 times more likely to have IC, with a prevalence of 2.2% in men and 1.2% in women.<xref ref-type="bibr" rid="article-80371.r13">[13]</xref>&#x000a0;However, a gender shift in prevalence occurs when the diagnosis of PAD is based on the ankle-brachial pressure index (ABI). For example, the Rotterdam study found the prevalence of ABI-based diagnosis of PAD to be 20.5% in women and 16.9% in adults, with a ratio of 0.82. Other studies, such as the Cardiovascular Health Study (CHS) and a population-based study, found no significant difference in ABI-based diagnosis of PAD between men and women. Proposed explanations for differences between ABI&#x000a0;versus IC-defined PAD gender differences are that women are more likely to have atypical and late presentations and have intrinsically lower ABI values.<xref ref-type="bibr" rid="article-80371.r14">[14]</xref></p>
        <p>Racial and socioeconomic disparities also exist. In regards to race, the CHS found African Americans to have an odds ratio of 2.12 for PAD compared to Non-Hispanic whites&#x000a0;when adjusting for known risk factors.<xref ref-type="bibr" rid="article-80371.r15">[15]</xref>&#x000a0;The compilation of three studies addressing the impact of race on the risk of PAD found&#x000a0;odds ratios of 2.3 to 3.1 for African Americans compared to Non-Hispanic whites when adjusting for confounders.<xref ref-type="bibr" rid="article-80371.r16">[16]</xref>&#x000a0;A&#x000a0;socioeconomic survey study found patients with lower poverty-income ratios (PIR) to have a nearly 2 fold increase in the risk of PAD compared to higher PIR. Furthermore, the study found a lower educational level to be significantly associated with PAD (OR 2.8, 95% CI 1.96&#x02013;4.0, p&#x0003c;0.0001).<xref ref-type="bibr" rid="article-80371.r17">[17]</xref></p>
      </sec>
      <sec id="article-80371.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Peripheral vascular disease is primarily driven by the progression of atherosclerotic disease leading to macro and microvascular dysfunction. PAD typically affects the lower extremity vascular beds, but larger arteries, such as the abdominal aorta and iliac arteries, are frequently&#x000a0;involved. More severe disease can involve multilevel and/or diffuse disease. The pathophysiology of atherosclerosis is a complex inflammatory response with the involvement of various vascular cells, thrombotic factors, and cholesterol&#x000a0;and inflammatory molecules.</p>
        <p>Atherosclerosis begins with lipoprotein accumulation within the intimal layer of&#x000a0;large arteries. The lipoprotein presence within the endothelium leads to lipid oxidation and cytokine response with the infiltration of lymphocytes and&#x000a0;macrophages.<xref ref-type="bibr" rid="article-80371.r18">[18]</xref>&#x000a0;Macrophages consume these oxidized lipids and form foam cells leading to the development of "fatty streaks."<xref ref-type="bibr" rid="article-80371.r19">[19]</xref>&#x000a0;Although not clinically significant, these fatty streaks can eventually develop into more advanced&#x000a0;plaques&#x000a0;consisting of necrotic lipid cores and smooth muscle cells (SMC). SMC and endothelial cells secrete cytokines and growth factors, leading to migration of SMC to the luminal side of the plaque and extracellular matrix synthesis and eventual&#x000a0;formation of a fibrous plaque.&#x000a0;Fibrous plaque stability is principally dependent on its composition, with more vulnerable plaques consisting of a thinner fibrous cap and more numerous inflammatory cells.</p>
        <p>Atherosclerotic plaque builds up slowly over decades within the wall of the vessel. Plaque accumulation results in vascular stenosis and frequent vascular dilation to maximize end-organ perfusion.&#x000a0;Once the vessel dilation capacity is maximized, the plaque continues to accumulate, which further compromises the lumen&#x000a0;occasionally, leading to critical narrowing of the artery. As narrowing progresses and obstructs the artery, collateral circulatory beds frequently develop to preserve distal perfusion and tissue viability.&#x000a0;These collateral circulatory pathways are unable to match the blood supply provided by a healthy vessel completely.&#x000a0;IC results when&#x000a0;blood flow distal to the occlusion is sufficiently compromised, resulting in fixed oxygen delivery that is unable to match oxygen demand.<xref ref-type="bibr" rid="article-80371.r20">[20]</xref>&#x000a0;The most severe form of&#x000a0;PAD is&#x000a0;critical limb ischemia, which&#x000a0;is defined as limb pain at rest or impending limb loss.<xref ref-type="bibr" rid="article-80371.r21">[21]</xref></p>
        <p>Acute ischemia may ensue if in-situ vascular thrombosis occurs or a cardioembolic source suddenly occludes the narrowed vessel.<xref ref-type="bibr" rid="article-80371.r22">[22]</xref>&#x000a0;Arterial thrombosis secondary to progressive atherosclerotic disease, and thrombosis represents 40% of acute limb ischemia (ALI) cases.<xref ref-type="bibr" rid="article-80371.r23">[23]</xref> Atherosclerotic fibrous plaque rupture leads to exposure of subendothelial collagen and inflammatory cells, causing platelet adhesion and aggregation with rapid in-situ thrombosis of the vessel. Patients with in-situ vascular thrombosis tend to have improved outcomes compared to embolic causes due to the presence of extensive collateral circulation. Embolic ALI causes represent 30% of ALI cases, with the femoral artery being the most common site.<xref ref-type="bibr" rid="article-80371.r23">[23]</xref> ALI is a vascular emergency with an immediate&#x000a0;physician consultation required for the preservation of limb viability.</p>
      </sec>
      <sec id="article-80371.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Diagnosis of peripheral vascular disease can be difficult due to the increasing prevalence of similarly presenting comorbid conditions and large numbers of patients having an asymptomatic or atypical presentation.<xref ref-type="bibr" rid="article-80371.r24">[24]</xref>&#x000a0;The clinical presentation of PAD is often dependent on the severity of arterial insufficiency and the presence of comorbid conditions, which may alter or mask the symptoms of underlying vascular disease.</p>
        <p>Atypical presentation of PAD occurs when patients have existing comorbidities such as lumbosacral disease, spinal stenosis, or advanced diabetes mellitus - all of which may alter the perception of pain.&#x000a0;Atypical pain is characterized by pain unrelated to physical activity, pain that occurs both at rest and exertion, and pain lasting longer than 10 minutes after exercise cessation.<xref ref-type="bibr" rid="article-80371.r25">[25]</xref>&#x000a0;Pseudo claudication refers to neuropathic pain observed in patients with spinal stenosis and can be differentiated from PAD with a thorough history and physical examination. Patients with pseudo claudication tend to have pain characterized by weakness and paresthesias that is irrespective of the degree of physical activity and usually is relieved by sitting down or changing body positioning rather than rest.<xref ref-type="bibr" rid="article-80371.r20">[20]</xref></p>
        <p>Patients with hemodynamically significant PAD based on ABI testing are more likely to have asymptomatic rather than symptomatic disease. This illustrates&#x000a0;the importance of maintaining a high clinical suspicion of&#x000a0;underlying PAD for effective secondary prevention. Over 50% of patients with PAD are asymptomatic.<xref ref-type="bibr" rid="article-80371.r26">[26]</xref>&#x000a0;The prevalence of asymptomatic PAD may partly be explained by older individuals misinterpreting their symptoms as normal aging processes. Additionally, patients with mild to moderate PAD&#x000a0;may be unable to exercise to a capacity where significant oxygen demand is required. Thus a mismatch between supply and demand does not occur, and patients remain asymptomatic.&#x000a0;</p>
        <p>Intermittent claudication is the most classic symptom of PAD, characterized by an exercise-induced cramping sensation with associated fatigue, weakness, and or pressure. It is not uncommon for patients to deny pain, and therefore asking about discomfort while ambulating is a more useful screening question. Symptoms are exacerbated by leg elevation and relieved by placing the limb in a dependent position. Paresthesias, lower extremity weakness, stiffness, and cool extremities may also be present. Anatomically the level of obstruction is usually seen one level above the area of discomfort; for example, patients with aortoiliac disease will have buttock and thigh symptoms. 70% to 80% of patients have stable intermittent claudication over 10 years; however, a portion of patients may progress through debilitating ischemic rest pain, critical limb ischemia, and eventual amputation.<xref ref-type="bibr" rid="article-80371.r27">[27]</xref>&#x000a0;Critical limb ischemia is manifested by pain at rest,&#x000a0;nonhealing wounds or ulcers, and gangrene in one or both legs.&#x000a0;</p>
        <p>The physical exam begins with a general inspection with attention to fingernail tar indicative of cigarette smoking, scars from previous vascular surgeries, and the presence of amputations. A focused cardiovascular examination begins with a pulse examination to determine rate, rhythm, and strength. Chest auscultation should be performed to evaluate for pulmonary diseases such as chronic obstructive pulmonary disease (COPD) and pulmonary fibrosis, and heart sounds or murmurs. Neurological examination is essential to evaluate for pseudo claudication. Examination of the limbs should involve assessment for pulselessness, pallor, muscular atrophy, cool or cyanotic skin, or pain with palpation.<xref ref-type="bibr" rid="article-80371.r28">[28]</xref>&#x000a0;Lower extremity ulcers may be arterial, venous, neuropathic, or a combination of two or more. Ulcers secondary to arterial insufficiency are tender and typically have ragged borders with a dry base and pale or necrotic centers.</p>
      </sec>
      <sec id="article-80371.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The diagnosis of peripheral vascular disease can be sufficiently made based on patient risk factors, clinical presentation, and physical exam findings.&#x000a0;Occasionally patients can present with atypical symptoms, and objective data can establish the diagnosis. Assessment begins with accounting for known PAD risk factors, including smoking, diabetes, hypertension, hypercholesterolemia, and obesity. Intermittent claudication must be distinguished from neurological, musculoskeletal, or vascular disorders, which may present similarly to PAD. Physical exam findings of the lower extremities may demonstrate shiny skin with coolness to palpation, reduced or absent pulses, abnormal capillary refill time, pallor with leg elevation, dependent rubor, and auscultation of bruits in major vessels, including the femoral and popliteal arteries.<xref ref-type="bibr" rid="article-80371.r29">[29]</xref>&#x000a0;Advanced disease may manifest as nonhealing ulcers or gangrene.</p>
        <p>Measurement of the ankle-brachial index (ABI) is a cost-effective&#x000a0;noninvasive objective measure for PAD diagnosis. The ABI is obtained by measuring the systolic ankle pressure ratio to the systolic brachial pressure. The test is performed by placing a blood pressure cuff above the level of the ankle and placing a Doppler ultrasonography probe on the dorsalis pedis or posterior tibialis and then inflating the cuff until the signal from the probe ceases. The cuff is then slowly deflated, and the return of the Doppler probe signal marks the systolic ankle pressure. The process is then repeated for the opposite leg.&#x000a0;The ankle pressure of each leg is then divided by the highest systolic pressure of either brachial artery. A normal ABI ratio ranges from 0.9 to 1.2, and values less than 0.9 are diagnostic of PAD. Noncompressible vessels, as seen in people with diabetes and those with advanced kidney disease and may have falsely elevated ratios.<xref ref-type="bibr" rid="article-80371.r30">[30]</xref>&#x000a0;Individuals with abnormally high ABI ratios have higher all-cause mortality compared to normal ABI ratios. Further diagnostic evaluation for these patients often warrants a toe-brachial index (TBI), which is the comparison of the toe systolic pressure to the higher systolic brachial pressure.<xref ref-type="bibr" rid="article-80371.r20">[20]</xref>&#x000a0;These particular patients illustrate the vital importance of clinical history and physical examination in the initial evaluation of patients with suspected PAD.</p>
        <p>Duplex ultrasonography is a safe and cost-effective method of determining PAD location, stenosis severity, and length of stenosis or occlusion. 2-dimensional imaging, along with color Doppler, provides an accurate assessment of lesion stenosis, hemodynamic severity, and plaque characteristics. Doppler ultrasonography can be used in routine follow-up post-procedure for surveillance of patency. This diagnostic modality can assist in decision-making when further intervention is contemplated.<xref ref-type="bibr" rid="article-80371.r31">[31]</xref>&#x000a0;</p>
        <p>Magnetic resonance angiography (MRA) or computed tomography angiography (CTA) both provide excellent high-quality vascular imaging. The advantages of MRA include the ability to identify small runoff vessels that sometimes may not be seen with digital subtraction angiography (DSA). Compared with DSA, MRA has 90% sensitivity and 97% specificity in identifying hemodynamically significant lesions.<xref ref-type="bibr" rid="article-80371.r31">[31]</xref>&#x000a0;CTA has similar diagnostic accuracy to MRA, with both imaging techniques useful for determining&#x000a0;candidacy for bypass surgery versus angioplasty.</p>
      </sec>
      <sec id="article-80371.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Patients diagnosed with peripheral vascular disease require a reasoned approach to account for age, risk factors, disease severity, and functional status. Management is divided into two broad categories aimed at decreasing cardiovascular events and improving symptoms. Persons with PAD are at increased risk of&#x000a0;coronary artery disease mortality (relative risk = 6.6), cardiovascular mortality (relative risk = 5.9), and all-cause mortality (relative risk = 3.1).<xref ref-type="bibr" rid="article-80371.r32">[32]</xref>&#x000a0;Therefore PAD management begins with&#x000a0;lifestyle modification&#x000a0;to prevent disease progression with the addition of medical and interventional therapy required&#x000a0;for improved symptomatic control and cardiovascular event risk reduction.</p>
        <p>
<bold>Cardiovascular Risk Factor Modification</bold>
</p>
        <p>Aggressive risk factors modification is essential to lowering cardiovascular risk. Smoking cessation reduces the risk of PAD progression, cardiovascular events, including myocardial infarction and stroke, and&#x000a0;critical limb ischemia.<xref ref-type="bibr" rid="article-80371.r33">[33]</xref>&#x000a0;Patient education, along with the use of behavioral therapy, nicotine replacement therapy, or pharmacological therapy, can be used to reduce smoking and improve cardiovascular outcomes. Statin therapy has been effectively shown to reduce cardiovascular events and all-cause mortality and reduce the need for revascularization and should be routinely used in patients with PAD. Hypertension management with blood pressure reduction to less than 140/90 in nondiabetic and 130/80 in diabetic patients has been shown to improve outcomes.<xref ref-type="bibr" rid="article-80371.r34">[34]</xref>&#x000a0;Diabetes is a risk factor for&#x000a0;symptomatic and asymptomatic PAD by 1.5 to 4 fold, respectively, and a hemoglobin A1c target of less than 7% should be achieved with less stringent goals for individuals with extensive comorbidities.<xref ref-type="bibr" rid="article-80371.r35">[35]</xref></p>
        <p>
<bold>Exercise Therapy</bold>
</p>
        <p>Randomized trials have shown supervised exercise therapy programs to have significant improvement in claudication symptoms. A meta-analysis of 27 studies found exercise significantly improved pain-free walking distance by 269 feet and total walking distance by nearly 400 feet.<xref ref-type="bibr" rid="article-80371.r36">[36]</xref>&#x000a0;Exercise programs typically consist of 30- to 45-minute length sessions conducted 4 to 5 times a week over the course of 12 weeks. A meta-analysis of five trials found no improvement in mortality with exercise therapy programs.<xref ref-type="bibr" rid="article-80371.r36">[36]</xref></p>
        <p>
<bold>Pharmacotherapy</bold>
</p>
        <p>Pharmacological therapy for intermittent claudication (IC) management can be offered to patients who have not benefited from exercise therapy and risk factor modification.<xref ref-type="bibr" rid="article-80371.r37">[37]</xref>&#x000a0;Two medications approved for IC treatment include cilostazol and naftidrofuryl. Cilostazol inhibits&#x000a0;phosphodiesterase type 3 and has demonstrated antiplatelet effect, vasodilatory properties, and inhibition of smooth muscle cell proliferation.<xref ref-type="bibr" rid="article-80371.r38">[38]</xref>&#x000a0;A meta-analysis of over 2000 patients found individuals on cilostazol had significantly longer pain-free and total walking distances.<xref ref-type="bibr" rid="article-80371.r38">[38]</xref>&#x000a0;Naftidrofuryl is a 5-hydroxytryptamine-2-receptor antagonist that inhibits glucose uptake and increases&#x000a0;adenosine triphosphate levels. It has fewer side effects than cilostazol and should be&#x000a0;considered&#x000a0;where available.<xref ref-type="bibr" rid="article-80371.r39">[39]</xref></p>
        <p>Daily aspirin is recommended for overall cardiovascular care. No consensus has been reached on the most effective dose.</p>
        <p>
<bold>Revascularization</bold>
</p>
        <p>Patients who have debilitating symptoms unresponsive to risk factor modification and exercise and pharmacological therapy may be candidates for endovascular, surgical, or combined endovascular and surgical intervention. Indications for intervention include individuals with incapacitating claudication interfering with daily activity and limb salvage in patients with critical limb ischemia manifested by ischemic pain at rest, ulceration, and gangrene. The decision on surgical versus percutaneous intervention is dependent on many factors,&#x000a0;including the patient's functional status and surgical risk, skills of the operator, anatomic location and extent of disease, presence of multifocal vascular lesions, and patient preference.<xref ref-type="bibr" rid="article-80371.r40">[40]</xref>&#x000a0;An interprofessional team approach involving an internist, interventionalist, and vascular surgeon should be undertaken for personalized patient care to improve outcomes and patient satisfaction.</p>
      </sec>
      <sec id="article-80371.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>A provider has to take into account various differential diagnoses when a patient presents with the above-mentioned signs and symptoms. Following are some of the most important ones:</p>
        <p>
<bold>Neurological</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Nerve root compression</p>
          </list-item>
          <list-item>
            <p>Spinal stenosis&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Peripheral neuropathy</p>
          </list-item>
          <list-item>
            <p>Nerve entrapment</p>
          </list-item>
        </list>
        <p>
<bold>Musculoskeletal</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Medial tibial stress syndrome</p>
          </list-item>
          <list-item>
            <p>Osteoarthritis&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Muscle strain</p>
          </list-item>
          <list-item>
            <p>Baker cyst</p>
          </list-item>
        </list>
        <p>
<bold>Vascular</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Chronic venous insufficiency</p>
          </list-item>
          <list-item>
            <p>Thrombophlebitis</p>
          </list-item>
          <list-item>
            <p>Deep venous thrombosis</p>
          </list-item>
          <list-item>
            <p>Raynaud phenomenon</p>
          </list-item>
          <list-item>
            <p>Thromboangiitis obliterans</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-80371.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The overall prognosis of patients with peripheral vascular disease must take into account patient risk factors, cardiovascular health, and disease severity. In terms of limb health at 5 years, nearly 80% of patients will have stable claudication symptoms. Only 1% to 2% of patients will progress to critical limb ischemia in 5 years.&#x000a0;20 to 30% of patients with PAD&#x000a0;will die within 5 years, with 75% of those deaths attributed to cardiovascular causes.<xref ref-type="bibr" rid="article-80371.r32">[32]</xref></p>
      </sec>
      <sec id="article-80371.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Peripheral vascular disease can affect several systems in the body leading to a number of complications as listed below:</p>
        <list list-type="bullet">
          <list-item>
            <p>Acute&#x000a0;coronary syndrome</p>
          </list-item>
          <list-item>
            <p>Stroke</p>
          </list-item>
          <list-item>
            <p>Nonhealing ulcer</p>
          </list-item>
          <list-item>
            <p>Gangrene</p>
          </list-item>
          <list-item>
            <p>Amputation</p>
          </list-item>
          <list-item>
            <p>Deep vein thrombosis</p>
          </list-item>
          <list-item>
            <p>Erectile dysfunction</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-80371.s12" sec-type="Consultations">
        <title>Consultations</title>
        <list list-type="bullet">
          <list-item>
            <p>Vascular surgery</p>
          </list-item>
          <list-item>
            <p>Interventional cardiology</p>
          </list-item>
          <list-item>
            <p>Endocrinology</p>
          </list-item>
          <list-item>
            <p>Radiology</p>
          </list-item>
          <list-item>
            <p>Internal medicine</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-80371.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patient management for the desired outcomes is based on a holistic approach that includes non-pharmacological lifestyle modification and pharmacological management, such as:</p>
        <list list-type="bullet">
          <list-item>
            <p>Smoking cessation</p>
          </list-item>
          <list-item>
            <p>Ambulatory blood pressure monitoring</p>
          </list-item>
          <list-item>
            <p>Medication and exercise therapy compliance</p>
          </list-item>
          <list-item>
            <p>Cholesterol management through diet and statin therapy</p>
          </list-item>
          <list-item>
            <p>Weight reduction</p>
          </list-item>
          <list-item>
            <p>HbA1c goal of less than 7% (or more for significant comorbid conditions or hypoglycemia)</p>
          </list-item>
          <list-item>
            <p>Regular follow up with an interprofessional team</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-80371.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Peripheral arterial disease is a progressive systemic disease with poor long-term outcomes. Although symptoms of claudication remain stable for many years, these patients are at high risk of fatal and nonfatal cardiovascular events. Interprofessional coordination is necessary for identifying patients at risk of disease, preventing secondary progression, and presenting patients with various options for their disease.&#x000a0;Primary care providers are essential for patient education regarding risk factors for cardiovascular&#x000a0;disease and management of tobacco abuse, hypercholesterolemia, hypertension, and diabetes mellitus.&#x000a0;Cardiologists should be involved, given nearly 75% of patients with PAD die from cardiovascular events. Vascular surgeons and&#x000a0;endovascular specialists' input provides patients with various&#x000a0;options for refractory disease. Vascular medicine specialists and podiatrists are very frequently vital members of the interprofessional team. Nurses&#x000a0;are valuable for their familiarity with the patient and for updates on how the patient's condition has progressed. Pharmacists are needed for patient and physician education on potential medication side effects and drug-to-drug interactions.</p>
        <p>Current guidelines by the American College of Cardiology recommend patients with symptoms of IC undergo ABI testing. [Level 2] Patients diagnosed with PAD and unresponsive to exercise therapy should receive cilostazol for symptomatic improvement and increased walking distance. [Level I] Endovascular procedures are recommended in patients who have not responded to exercise and pharmacological therapy and who have debilitating symptoms.<xref ref-type="bibr" rid="article-80371.r34">[34]</xref> [Level 1]&#x000a0;</p>
      </sec>
      <sec id="article-80371.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=80371&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=80371">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/health/peripheral-vascular-disease/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=80371">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/80371/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=80371">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-80371.s16">
        <fig id="article-80371.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Peripheral Arterial Disease
Non-healing necrotic ulceration and gangrene of the 3rd digit secondary to PAD. Contributed by Mark A. Dreyer, DPM, FACFAS</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Peripheral__Arterial__Disease" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-80371.s17">
        <fig id="article-80371.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Peripheral Arterial Disease - High Grade Stenosis of Dorsalis Pedis Artery of the foot. Contribution by Mark A. Dreyer, DPM, FACFAS</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="IMG_5807" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-80371.s18">
        <fig id="article-80371.image.f3" position="float" orientation="portrait">
          <caption>
            <p>Peripheral Arterial Disease - Chronic Total Occlusion of Left Superficial Femoral Artery Contribution by Mark A. Dreyer, DPM, FACFAS</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="unnamed-6" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-80371.s19">
        <fig id="article-80371.image.f4" position="float" orientation="portrait">
          <caption>
            <p>Peripheral Arterial Disease - Chronic Total Occlusion of Left Superficial Femoral Artery after atherectomy. Contribution by Mark A. Dreyer, DPM, FACFAS</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="unnamed-5" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-80371.s20">
        <fig id="article-80371.image.f5" position="float" orientation="portrait">
          <caption>
            <p>Peripheral Arterial Disease - Occluded anterior tibial artery Contribution by Mark A. Dreyer, DPM, FACFAS</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="IMG_5808" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-80371.s21">
        <title>References</title>
        <ref id="article-80371.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <collab>European Stroke Organisation</collab>
              <name>
                <surname>Tendera</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Aboyans</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Bartelink</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Baumgartner</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Cl&#x000e9;ment</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Collet</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Cremonesi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>De Carlo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Erbel</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Fowkes</surname>
                <given-names>FG</given-names>
              </name>
              <name>
                <surname>Heras</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kownator</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Minar</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ostergren</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Poldermans</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Riambau</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Roffi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>R&#x000f6;ther</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sievert</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>van Sambeek</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zeller</surname>
                <given-names>T</given-names>
              </name>
              <collab>ESC Committee for Practice Guidelines</collab>
            </person-group>
            <article-title>ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC).</article-title>
            <source>Eur Heart J</source>
            <year>2011</year>
            <month>Nov</month>
            <volume>32</volume>
            <issue>22</issue>
            <fpage>2851</fpage>
            <page-range>2851-906</page-range>
            <pub-id pub-id-type="pmid">21873417</pub-id>
          </element-citation>
        </ref>
        <ref id="article-80371.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Meijer</surname>
                <given-names>WT</given-names>
              </name>
              <name>
                <surname>Grobbee</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Hunink</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Hofman</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hoes</surname>
                <given-names>AW</given-names>
              </name>
            </person-group>
            <article-title>Determinants of peripheral arterial disease in the elderly: the Rotterdam study.</article-title>
            <source>Arch Intern Med</source>
            <year>2000</year>
            <month>Oct</month>
            <day>23</day>
            <volume>160</volume>
            <issue>19</issue>
            <fpage>2934</fpage>
            <page-range>2934-8</page-range>
            <pub-id pub-id-type="pmid">11041900</pub-id>
          </element-citation>
        </ref>
        <ref id="article-80371.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fowkes</surname>
                <given-names>FG</given-names>
              </name>
              <name>
                <surname>Rudan</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Rudan</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Aboyans</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Denenberg</surname>
                <given-names>JO</given-names>
              </name>
              <name>
                <surname>McDermott</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Norman</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Sampson</surname>
                <given-names>UK</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Mensah</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Criqui</surname>
                <given-names>MH</given-names>
              </name>
            </person-group>
            <article-title>Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis.</article-title>
            <source>Lancet</source>
            <year>2013</year>
            <month>Oct</month>
            <day>19</day>
            <volume>382</volume>
            <issue>9901</issue>
            <fpage>1329</fpage>
            <page-range>1329-40</page-range>
            <pub-id pub-id-type="pmid">23915883</pub-id>
          </element-citation>
        </ref>
        <ref id="article-80371.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Krishna</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Moxon</surname>
                <given-names>JV</given-names>
              </name>
              <name>
                <surname>Golledge</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>A review of the pathophysiology and potential biomarkers for peripheral artery disease.</article-title>
            <source>Int J Mol Sci</source>
            <year>2015</year>
            <month>May</month>
            <day>18</day>
            <volume>16</volume>
            <issue>5</issue>
            <fpage>11294</fpage>
            <page-range>11294-322</page-range>
            <pub-id pub-id-type="pmid">25993296</pub-id>
          </element-citation>
        </ref>
        <ref id="article-80371.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Subherwal</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Kober</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Peterson</surname>
                <given-names>ED</given-names>
              </name>
              <name>
                <surname>Bhatt</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Gislason</surname>
                <given-names>GH</given-names>
              </name>
              <name>
                <surname>Olsen</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>WS</given-names>
              </name>
              <name>
                <surname>Torp-Pedersen</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Fosbol</surname>
                <given-names>EL</given-names>
              </name>
            </person-group>
            <article-title>Peripheral artery disease is a coronary heart disease risk equivalent among both men and women: results from a nationwide study.</article-title>
            <source>Eur J Prev Cardiol</source>
            <year>2015</year>
            <month>Mar</month>
            <volume>22</volume>
            <issue>3</issue>
            <fpage>317</fpage>
            <page-range>317-25</page-range>
            <pub-id pub-id-type="pmid">24398369</pub-id>
          </element-citation>
        </ref>
        <ref id="article-80371.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wakabayashi</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Sotoda</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>[Alcohol drinking and peripheral arterial disease of lower extremity].</article-title>
            <source>Nihon Arukoru Yakubutsu Igakkai Zasshi</source>
            <year>2014</year>
            <month>Feb</month>
            <volume>49</volume>
            <issue>1</issue>
            <fpage>13</fpage>
            <page-range>13-27</page-range>
            <pub-id pub-id-type="pmid">24818355</pub-id>
          </element-citation>
        </ref>
        <ref id="article-80371.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Periard</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Cavassini</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Taff&#x000e9;</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Chevalley</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Senn</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Chapuis-Taillard</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>de Valli&#x000e8;re</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hayoz</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Tarr</surname>
                <given-names>PE</given-names>
              </name>
              <collab>Swiss HIV Cohort Study</collab>
            </person-group>
            <article-title>High prevalence of peripheral arterial disease in HIV-infected persons.</article-title>
            <source>Clin Infect Dis</source>
            <year>2008</year>
            <month>Mar</month>
            <day>01</day>
            <volume>46</volume>
            <issue>5</issue>
            <fpage>761</fpage>
            <page-range>761-7</page-range>
            <pub-id pub-id-type="pmid">18230043</pub-id>
          </element-citation>
        </ref>
        <ref id="article-80371.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khandanpour</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Loke</surname>
                <given-names>YK</given-names>
              </name>
              <name>
                <surname>Meyer</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Jennings</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Armon</surname>
                <given-names>MP</given-names>
              </name>
            </person-group>
            <article-title>Homocysteine and peripheral arterial disease: systematic review and meta-analysis.</article-title>
            <source>Eur J Vasc Endovasc Surg</source>
            <year>2009</year>
            <month>Sep</month>
            <volume>38</volume>
            <issue>3</issue>
            <fpage>316</fpage>
            <page-range>316-22</page-range>
            <pub-id pub-id-type="pmid">19560951</pub-id>
          </element-citation>
        </ref>
        <ref id="article-80371.r9">
          <label>9</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Sampson</surname>
                <given-names>UKA</given-names>
              </name>
              <name>
                <surname>Fowkes</surname>
                <given-names>FGR</given-names>
              </name>
              <name>
                <surname>Naidoo</surname>
                <given-names>NG</given-names>
              </name>
              <name>
                <surname>Criqui</surname>
                <given-names>MH</given-names>
              </name>
            </person-group>
            <chapter-title>Peripheral Artery Disease</chapter-title>
            <person-group person-group-type="editor">
              <name>
                <surname>Prabhakaran</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Anand</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gaziano</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Mbanya</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Nugent</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <source>Cardiovascular, Respiratory, and Related Disorders</source>
            <edition>3rd</edition>
            <publisher-name>The International Bank for Reconstruction and Development / The World Bank</publisher-name>
            <publisher-loc>Washington (DC)</publisher-loc>
            <year>2017</year>
            <month>11</month>
            <day>17</day>
            <pub-id pub-id-type="pmid">30212080</pub-id>
          </element-citation>
        </ref>
        <ref id="article-80371.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Benjamin</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Muntner</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Alonso</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bittencourt</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Callaway</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Carson</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Chamberlain</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Das</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Delling</surname>
                <given-names>FN</given-names>
              </name>
              <name>
                <surname>Djousse</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Elkind</surname>
                <given-names>MSV</given-names>
              </name>
              <name>
                <surname>Ferguson</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Fornage</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jordan</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Kissela</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Knutson</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Kwan</surname>
                <given-names>TW</given-names>
              </name>
              <name>
                <surname>Lackland</surname>
                <given-names>DT</given-names>
              </name>
              <name>
                <surname>Lewis</surname>
                <given-names>TT</given-names>
              </name>
              <name>
                <surname>Lichtman</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Longenecker</surname>
                <given-names>CT</given-names>
              </name>
              <name>
                <surname>Loop</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Lutsey</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Matsushita</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Moran</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Mussolino</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>O'Flaherty</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pandey</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Perak</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Rosamond</surname>
                <given-names>WD</given-names>
              </name>
              <name>
                <surname>Roth</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Sampson</surname>
                <given-names>UKA</given-names>
              </name>
              <name>
                <surname>Satou</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Schroeder</surname>
                <given-names>EB</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Spartano</surname>
                <given-names>NL</given-names>
              </name>
              <name>
                <surname>Stokes</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tirschwell</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Tsao</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Turakhia</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>VanWagner</surname>
                <given-names>LB</given-names>
              </name>
              <name>
                <surname>Wilkins</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Virani</surname>
                <given-names>SS</given-names>
              </name>
              <collab>American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee</collab>
            </person-group>
            <article-title>Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association.</article-title>
            <source>Circulation</source>
            <year>2019</year>
            <month>Mar</month>
            <day>05</day>
            <volume>139</volume>
            <issue>10</issue>
            <fpage>e56</fpage>
            <page-range>e56-e528</page-range>
            <pub-id pub-id-type="pmid">30700139</pub-id>
          </element-citation>
        </ref>
        <ref id="article-80371.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Santulli</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Update on peripheral artery disease: Epidemiology and evidence-based facts.</article-title>
            <source>Atherosclerosis</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>275</volume>
            <fpage>379</fpage>
            <page-range>379-381</page-range>
            <pub-id pub-id-type="pmid">29843915</pub-id>
          </element-citation>
        </ref>
        <ref id="article-80371.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kannel</surname>
                <given-names>WB</given-names>
              </name>
              <name>
                <surname>McGee</surname>
                <given-names>DL</given-names>
              </name>
            </person-group>
            <article-title>Update on some epidemiologic features of intermittent claudication: the Framingham Study.</article-title>
            <source>J Am Geriatr Soc</source>
            <year>1985</year>
            <month>Jan</month>
            <volume>33</volume>
            <issue>1</issue>
            <fpage>13</fpage>
            <page-range>13-8</page-range>
            <pub-id pub-id-type="pmid">3965550</pub-id>
          </element-citation>
        </ref>
        <ref id="article-80371.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Murabito</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Evans</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Nieto</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Larson</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>PW</given-names>
              </name>
            </person-group>
            <article-title>Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study.</article-title>
            <source>Am Heart J</source>
            <year>2002</year>
            <month>Jun</month>
            <volume>143</volume>
            <issue>6</issue>
            <fpage>961</fpage>
            <page-range>961-5</page-range>
            <pub-id pub-id-type="pmid">12075249</pub-id>
          </element-citation>
        </ref>
        <ref id="article-80371.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aboyans</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Criqui</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>McClelland</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Allison</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>McDermott</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Goff</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Manolio</surname>
                <given-names>TA</given-names>
              </name>
            </person-group>
            <article-title>Intrinsic contribution of gender and ethnicity to normal ankle-brachial index values: the Multi-Ethnic Study of Atherosclerosis (MESA).</article-title>
            <source>J Vasc Surg</source>
            <year>2007</year>
            <month>Feb</month>
            <volume>45</volume>
            <issue>2</issue>
            <fpage>319</fpage>
            <page-range>319-27</page-range>
            <pub-id pub-id-type="pmid">17264011</pub-id>
          </element-citation>
        </ref>
        <ref id="article-80371.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Newman</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Siscovick</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Manolio</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Polak</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fried</surname>
                <given-names>LP</given-names>
              </name>
              <name>
                <surname>Borhani</surname>
                <given-names>NO</given-names>
              </name>
              <name>
                <surname>Wolfson</surname>
                <given-names>SK</given-names>
              </name>
            </person-group>
            <article-title>Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group.</article-title>
            <source>Circulation</source>
            <year>1993</year>
            <month>Sep</month>
            <volume>88</volume>
            <issue>3</issue>
            <fpage>837</fpage>
            <page-range>837-45</page-range>
            <pub-id pub-id-type="pmid">8353913</pub-id>
          </element-citation>
        </ref>
        <ref id="article-80371.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Criqui</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Aboyans</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology of peripheral artery disease.</article-title>
            <source>Circ Res</source>
            <year>2015</year>
            <month>Apr</month>
            <day>24</day>
            <volume>116</volume>
            <issue>9</issue>
            <fpage>1509</fpage>
            <page-range>1509-26</page-range>
            <pub-id pub-id-type="pmid">25908725</pub-id>
          </element-citation>
        </ref>
        <ref id="article-80371.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pande</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Creager</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Socioeconomic inequality and peripheral artery disease prevalence in US adults.</article-title>
            <source>Circ Cardiovasc Qual Outcomes</source>
            <year>2014</year>
            <month>Jul</month>
            <volume>7</volume>
            <issue>4</issue>
            <fpage>532</fpage>
            <page-range>532-9</page-range>
            <pub-id pub-id-type="pmid">24987053</pub-id>
          </element-citation>
        </ref>
        <ref id="article-80371.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rafieian-Kopaei</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Setorki</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Doudi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Baradaran</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nasri</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Atherosclerosis: process, indicators, risk factors and new hopes.</article-title>
            <source>Int J Prev Med</source>
            <year>2014</year>
            <month>Aug</month>
            <volume>5</volume>
            <issue>8</issue>
            <fpage>927</fpage>
            <page-range>927-46</page-range>
            <pub-id pub-id-type="pmid">25489440</pub-id>
          </element-citation>
        </ref>
        <ref id="article-80371.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lusis</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <article-title>Atherosclerosis.</article-title>
            <source>Nature</source>
            <year>2000</year>
            <month>Sep</month>
            <day>14</day>
            <volume>407</volume>
            <issue>6801</issue>
            <fpage>233</fpage>
            <page-range>233-41</page-range>
            <pub-id pub-id-type="pmid">11001066</pub-id>
          </element-citation>
        </ref>
        <ref id="article-80371.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Olin</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Sealove</surname>
                <given-names>BA</given-names>
              </name>
            </person-group>
            <article-title>Peripheral artery disease: current insight into the disease and its diagnosis and management.</article-title>
            <source>Mayo Clin Proc</source>
            <year>2010</year>
            <month>Jul</month>
            <volume>85</volume>
            <issue>7</issue>
            <fpage>678</fpage>
            <page-range>678-92</page-range>
            <pub-id pub-id-type="pmid">20592174</pub-id>
          </element-citation>
        </ref>
        <ref id="article-80371.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Varu</surname>
                <given-names>VN</given-names>
              </name>
              <name>
                <surname>Hogg</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Kibbe</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>Critical limb ischemia.</article-title>
            <source>J Vasc Surg</source>
            <year>2010</year>
            <month>Jan</month>
            <volume>51</volume>
            <issue>1</issue>
            <fpage>230</fpage>
            <page-range>230-41</page-range>
            <pub-id pub-id-type="pmid">20117502</pub-id>
          </element-citation>
        </ref>
        <ref id="article-80371.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>HO</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Elucidation of the Diagnosis and Treatment of Peripheral Arterial Disease.</article-title>
            <source>Korean Circ J</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>48</volume>
            <issue>9</issue>
            <fpage>826</fpage>
            <page-range>826-827</page-range>
            <pub-id pub-id-type="pmid">30088357</pub-id>
          </element-citation>
        </ref>
        <ref id="article-80371.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Olinic</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Stanek</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>T&#x00103;taru</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Homorodean</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Olinic</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Acute Limb Ischemia: An Update on Diagnosis and Management.</article-title>
            <source>J Clin Med</source>
            <year>2019</year>
            <month>Aug</month>
            <day>14</day>
            <volume>8</volume>
            <issue>8</issue>
            <pub-id pub-id-type="pmid">31416204</pub-id>
          </element-citation>
        </ref>
        <ref id="article-80371.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dhaliwal</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Mukherjee</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Peripheral arterial disease: Epidemiology, natural history, diagnosis and treatment.</article-title>
            <source>Int J Angiol</source>
            <year>2007</year>
            <season>Summer</season>
            <volume>16</volume>
            <issue>2</issue>
            <fpage>36</fpage>
            <page-range>36-44</page-range>
            <pub-id pub-id-type="pmid">22477268</pub-id>
          </element-citation>
        </ref>
        <ref id="article-80371.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McDermott</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Greenland</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Guralnik</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Criqui</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Dolan</surname>
                <given-names>NC</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Celic</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Pearce</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Schneider</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Clark</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Gibson</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>GJ</given-names>
              </name>
            </person-group>
            <article-title>Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment.</article-title>
            <source>JAMA</source>
            <year>2001</year>
            <month>Oct</month>
            <day>03</day>
            <volume>286</volume>
            <issue>13</issue>
            <fpage>1599</fpage>
            <page-range>1599-606</page-range>
            <pub-id pub-id-type="pmid">11585483</pub-id>
          </element-citation>
        </ref>
        <ref id="article-80371.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>H&#x000f8;yer</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Sandermann</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Petersen</surname>
                <given-names>LJ</given-names>
              </name>
            </person-group>
            <article-title>The toe-brachial index in the diagnosis of peripheral arterial disease.</article-title>
            <source>J Vasc Surg</source>
            <year>2013</year>
            <month>Jul</month>
            <volume>58</volume>
            <issue>1</issue>
            <fpage>231</fpage>
            <page-range>231-8</page-range>
            <pub-id pub-id-type="pmid">23688630</pub-id>
          </element-citation>
        </ref>
        <ref id="article-80371.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dormandy</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Rutherford</surname>
                <given-names>RB</given-names>
              </name>
            </person-group>
            <article-title>Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC).</article-title>
            <source>J Vasc Surg</source>
            <year>2000</year>
            <month>Jan</month>
            <volume>31</volume>
            <issue>1 Pt 2</issue>
            <fpage>S1</fpage>
            <page-range>S1-S296</page-range>
            <pub-id pub-id-type="pmid">10666287</pub-id>
          </element-citation>
        </ref>
        <ref id="article-80371.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bailey</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Griffin</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Scott</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>Clinical assessment of patients with peripheral arterial disease.</article-title>
            <source>Semin Intervent Radiol</source>
            <year>2014</year>
            <month>Dec</month>
            <volume>31</volume>
            <issue>4</issue>
            <fpage>292</fpage>
            <page-range>292-9</page-range>
            <pub-id pub-id-type="pmid">25435653</pub-id>
          </element-citation>
        </ref>
        <ref id="article-80371.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hennion</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Siano</surname>
                <given-names>KA</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and treatment of peripheral arterial disease.</article-title>
            <source>Am Fam Physician</source>
            <year>2013</year>
            <month>Sep</month>
            <day>01</day>
            <volume>88</volume>
            <issue>5</issue>
            <fpage>306</fpage>
            <page-range>306-10</page-range>
            <pub-id pub-id-type="pmid">24010393</pub-id>
          </element-citation>
        </ref>
        <ref id="article-80371.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Resnick</surname>
                <given-names>HE</given-names>
              </name>
              <name>
                <surname>Lindsay</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>McDermott</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Devereux</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Fabsitz</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Howard</surname>
                <given-names>BV</given-names>
              </name>
            </person-group>
            <article-title>Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study.</article-title>
            <source>Circulation</source>
            <year>2004</year>
            <month>Feb</month>
            <day>17</day>
            <volume>109</volume>
            <issue>6</issue>
            <fpage>733</fpage>
            <page-range>733-9</page-range>
            <pub-id pub-id-type="pmid">14970108</pub-id>
          </element-citation>
        </ref>
        <ref id="article-80371.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Olin</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Kaufman</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Bluemke</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Bonow</surname>
                <given-names>RO</given-names>
              </name>
              <name>
                <surname>Gerhard</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Jaff</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Rubin</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Hall</surname>
                <given-names>W</given-names>
              </name>
              <collab>American Heart Association</collab>
            </person-group>
            <article-title>Atherosclerotic Vascular Disease Conference: Writing Group IV: imaging.</article-title>
            <source>Circulation</source>
            <year>2004</year>
            <month>Jun</month>
            <day>01</day>
            <volume>109</volume>
            <issue>21</issue>
            <fpage>2626</fpage>
            <page-range>2626-33</page-range>
            <pub-id pub-id-type="pmid">15173045</pub-id>
          </element-citation>
        </ref>
        <ref id="article-80371.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Criqui</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Langer</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Fronek</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Feigelson</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Klauber</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>McCann</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Browner</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Mortality over a period of 10 years in patients with peripheral arterial disease.</article-title>
            <source>N Engl J Med</source>
            <year>1992</year>
            <month>Feb</month>
            <day>06</day>
            <volume>326</volume>
            <issue>6</issue>
            <fpage>381</fpage>
            <page-range>381-6</page-range>
            <pub-id pub-id-type="pmid">1729621</pub-id>
          </element-citation>
        </ref>
        <ref id="article-80371.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jonason</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bergstr&#x000f6;m</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Cessation of smoking in patients with intermittent claudication. Effects on the risk of peripheral vascular complications, myocardial infarction and mortality.</article-title>
            <source>Acta Med Scand</source>
            <year>1987</year>
            <volume>221</volume>
            <issue>3</issue>
            <fpage>253</fpage>
            <page-range>253-60</page-range>
            <pub-id pub-id-type="pmid">3591463</pub-id>
          </element-citation>
        </ref>
        <ref id="article-80371.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hirsch</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Haskal</surname>
                <given-names>ZJ</given-names>
              </name>
              <name>
                <surname>Hertzer</surname>
                <given-names>NR</given-names>
              </name>
              <name>
                <surname>Bakal</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Creager</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Halperin</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Hiratzka</surname>
                <given-names>LF</given-names>
              </name>
              <name>
                <surname>Murphy</surname>
                <given-names>WR</given-names>
              </name>
              <name>
                <surname>Olin</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Puschett</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Rosenfield</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Sacks</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Stanley</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>White</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>White</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>White</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Antman</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Adams</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Faxon</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Fuster</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Gibbons</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Hunt</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Jacobs</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Nishimura</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ornato</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Page</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Riegel</surname>
                <given-names>B</given-names>
              </name>
              <collab>American Association for Vascular Surgery</collab>
              <collab>Society for Vascular Surgery</collab>
              <collab>Society for Cardiovascular Angiography and Interventions</collab>
              <collab>Society for Vascular Medicine and Biology</collab>
              <collab>Society of Interventional Radiology</collab>
              <collab>ACC/AHA Task Force on Practice Guidelines Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease</collab>
              <collab>American Association of Cardiovascular and Pulmonary Rehabilitation</collab>
              <collab>National Heart, Lung, and Blood Institute</collab>
              <collab>Society for Vascular Nursing</collab>
              <collab>TransAtlantic Inter-Society Consensus</collab>
              <collab>Vascular Disease Foundation</collab>
            </person-group>
            <article-title>ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation.</article-title>
            <source>Circulation</source>
            <year>2006</year>
            <month>Mar</month>
            <day>21</day>
            <volume>113</volume>
            <issue>11</issue>
            <fpage>e463</fpage>
            <page-range>e463-654</page-range>
            <pub-id pub-id-type="pmid">16549646</pub-id>
          </element-citation>
        </ref>
        <ref id="article-80371.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <collab>American Diabetes Association</collab>
            <article-title>2. Classification and Diagnosis of Diabetes.</article-title>
            <source>Diabetes Care</source>
            <year>2016</year>
            <month>Jan</month>
            <volume>39 Suppl 1</volume>
            <fpage>S13</fpage>
            <page-range>S13-22</page-range>
            <pub-id pub-id-type="pmid">26696675</pub-id>
          </element-citation>
        </ref>
        <ref id="article-80371.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lane</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Harwood</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Watson</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Leng</surname>
                <given-names>GC</given-names>
              </name>
            </person-group>
            <article-title>Exercise for intermittent claudication.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2017</year>
            <month>Dec</month>
            <day>26</day>
            <volume>12</volume>
            <issue>12</issue>
            <fpage>CD000990</fpage>
            <pub-id pub-id-type="pmid">29278423</pub-id>
          </element-citation>
        </ref>
        <ref id="article-80371.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <collab>Society for Vascular Surgery Lower Extremity Guidelines Writing Group</collab>
              <name>
                <surname>Conte</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Pomposelli</surname>
                <given-names>FB</given-names>
              </name>
              <name>
                <surname>Clair</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Geraghty</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>McKinsey</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Mills</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Moneta</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Murad</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Powell</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Reed</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Schanzer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sidawy</surname>
                <given-names>AN</given-names>
              </name>
              <collab>Society for Vascular Surgery</collab>
            </person-group>
            <article-title>Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication.</article-title>
            <source>J Vasc Surg</source>
            <year>2015</year>
            <month>Mar</month>
            <volume>61</volume>
            <issue>3 Suppl</issue>
            <fpage>2S</fpage>
            <page-range>2S-41S</page-range>
            <pub-id pub-id-type="pmid">25638515</pub-id>
          </element-citation>
        </ref>
        <ref id="article-80371.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thompson</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>Zimet</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Forbes</surname>
                <given-names>WP</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Meta-analysis of results from eight randomized, placebo-controlled trials on the effect of cilostazol on patients with intermittent claudication.</article-title>
            <source>Am J Cardiol</source>
            <year>2002</year>
            <month>Dec</month>
            <day>15</day>
            <volume>90</volume>
            <issue>12</issue>
            <fpage>1314</fpage>
            <page-range>1314-9</page-range>
            <pub-id pub-id-type="pmid">12480040</pub-id>
          </element-citation>
        </ref>
        <ref id="article-80371.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Norgren</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Hiatt</surname>
                <given-names>WR</given-names>
              </name>
              <name>
                <surname>Dormandy</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Nehler</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Harris</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Fowkes</surname>
                <given-names>FG</given-names>
              </name>
              <collab>TASC II Working Group</collab>
            </person-group>
            <article-title>Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).</article-title>
            <source>J Vasc Surg</source>
            <year>2007</year>
            <month>Jan</month>
            <volume>45 Suppl S</volume>
            <fpage>S5</fpage>
            <page-range>S5-67</page-range>
            <pub-id pub-id-type="pmid">17223489</pub-id>
          </element-citation>
        </ref>
        <ref id="article-80371.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Comerota</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <article-title>Endovascular and surgical revascularization for patients with intermittent claudication.</article-title>
            <source>Am J Cardiol</source>
            <year>2001</year>
            <month>Jun</month>
            <day>28</day>
            <volume>87</volume>
            <issue>12A</issue>
            <fpage>34D</fpage>
            <page-range>34D-43D</page-range>
            <pub-id pub-id-type="pmid">11434898</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
